RNA sequencing reveals novel LncRNA/mRNAs co-expression network associated with puerarin-mediated inhibition of cardiac hypertrophy in mice
Authors:
Open Access
Abstract
Background: Evidence has demonstrated that puerarin is a potential medicine for the treatment of cardiac hypertrophy. However, the precise underlying molecular mechanisms of the protective effect of puerarin are still unclear. Here, we aimed to explore the regulatory mechanisms of lncRNAs/mRNAs co-expression network in a cardiac hypertrophy mouse model after puerarin treatment. Methods: A mouse model of cardiac hypertrophy was established by transverse aortic constriction (TAC). The echocardiography, tissue staining and western blot were used to examine the protective effect of puerarin. Then RNA sequencing (RNA-seq) was carried out to analyze systematically mRNAs and lncRNAs expression. The target lncRNA were confirmed using qRT-PCR. Moreover, a coding/non-coding gene co-expression network were established to find the interaction of lncRNA and mRNAs. The biological process, cellular component, molecular function and pathways of different expression mRNAs targeted by lncRNA were explored using Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis. Results: Puerarin exhibited an obvious inhibitory effect in cardiac hypertrophy in TAC model. RNA-seq analysis was performed to investigate the lncRNAs and mRNAs expression patterns of cardiomyocytes in sham and TAC groups treated with or without puerarin. RNA-seq identified that TAC downregulated four lncRNAs, which could be revised by puerarin treatment (|log2 Fold change| > 2 and FDR < 0.05). Among them, expression alterations of lncRNA Airn (antisense of Igf2r non-protein coding RNA) was confirmed by qRT-PCR. Pearson’s correlation coefficients of co-expression levels suggested that there was an interactive relationship between Airn and 2,387 mRNAs (r > 0.95 or r < −0.95). Those co-expressed mRNAs were enriched in some important biological processes such as translational initiation, cell proliferation, insulin-like growth factor binding and poly(A) RNA binding. KEGG analyses suggested that those Airn-interacted mRNAs were enriched in endocytosis, signaling pathways regulating pluripotency of stem cells and the Jak-STAT pathway. Conclusion: Puerarin may exert beneficial effects on cardiac hypertrophy through regulating the lncRNAs/mRNAs co-expression network.Keywords
All Related Versions
Funding Information
- Medical Scientific Research Foundation of Guangdong Province (A2020106)
This publication has 41 references indexed in Scilit:
- Developmental transcriptome profiling of bovine muscle tissue reveals an abundant GosB that regulates myoblast proliferation and apoptosisOncotarget, 2017
- Myocardial reverse remodeling: how far can we rewind?American Journal of Physiology-Heart and Circulatory Physiology, 2016
- Circular RNA expression alterations are involved in OGD/R-induced neuron injuryBiochemical and Biophysical Research Communications, 2016
- Puerarin prevents cardiac hypertrophy induced by pressure overload through activation of autophagyBiochemical and Biophysical Research Communications, 2015
- A long noncoding RNA protects the heart from pathological hypertrophyNature, 2014
- Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathwaysActa Pharmacologica Sinica, 2014
- Imprinted Igf2r silencing depends on continuous Airn lncRNA expression and is not restricted to a developmental windowDevelopment, 2013
- Airn Transcriptional Overlap, But Not Its lncRNA Products, Induces Imprinted Igf2r SilencingScience, 2012
- Diagnosis and Prognosis of Fetal Cardiomyopathies: A ReviewCurrent Pharmaceutical Design, 2010
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008